JORDI CARRERA

Jordi Carrera is a distinguished Venture Partner at Asabys Partners, a leading venture capital firm renowned for its strategic investments in the healthcare and life sciences sectors. In his pivotal role, Jordi is instrumental in sourcing, evaluating, and executing investment opportunities that align with Asabys Partners' mission to back transformative companies addressing critical medical needs and improving patient outcomes.

Asabys Partners focuses on a broad spectrum of healthcare innovations, including biotechnology, digital health, medical devices, and diagnostics. Jordi Carrera's expertise is particularly valuable in identifying disruptive technologies and business models within these areas. He works closely with founding teams, providing strategic guidance, operational support, and access to an extensive network of industry experts, clinicians, and corporate partners. His hands-on approach helps portfolio companies navigate complex regulatory landscapes, accelerate product development, and scale their operations effectively.

While specific past investments are proprietary, Jordi's work at Asabys Partners reflects the firm's commitment to investing in companies poised for significant impact. He is known for his keen eye for innovation and his ability to assess both the scientific merit and commercial viability of early-stage ventures. His contributions are vital in shaping the investment thesis for new opportunities and ensuring that Asabys Partners continues to be a preferred partner for ambitious healthcare entrepreneurs.

Jordi's career background likely includes a blend of entrepreneurial experience, corporate development, and previous roles within the venture capital ecosystem, providing him with a comprehensive understanding of the challenges and opportunities inherent in building successful healthcare companies. This diverse experience equips him to offer invaluable insights, from strategic planning and fundraising to market access and international expansion. His dedication to fostering innovation and supporting the growth of promising healthcare startups underscores his commitment to advancing medical science and delivering tangible benefits to society.